Showing Results for
- Academic Journals (820)
Search Results
- 820
Academic Journals
- 820
-
From:Reactions Weekly (Issue 1314)* Men who use erectile dysfunction (ED) drugs have higher rates of sexually transmitted diseases (STDs) than nonusers, according to US-based analysis of claims data. A cohort of about 1.4 million men (aged > 40 years)...
-
From:Clinical Advisor (Vol. 9, Issue 2)SILDENAFIL (Viagra) appears to be an effective and safe treatment for erectile dysfunction (ED) in men with mild-to-moderate heart failure, according to a small study. Twenty men (aged 48-88) with left ventricular...
-
From:Family Practice News (Vol. 35, Issue 3)NEW ORLEANS -- Regardless of glycemic control, vardenafil significantly improves intercourse success rates, compared with placebo, for diabetic men who do not respond to sildenafil, Culley Carson, M.D., reported in a...
-
From:MedSurg Nursing (Vol. 19, Issue 3) Peer-ReviewedErectile dysfunction (ED) affects about 30 million men in the United States, with incidence increasing with age (National Institutes of Health [NIH], 2009). Erectile dysfunction is defined as the inability of a man to...
-
From:Canadian Journal of Physiology and Pharmacology (Vol. 88, Issue 7) Peer-ReviewedIt has been reported that sodium nitrite (NaN[O.sub.2]) can act as a storage form of nitric oxide (NO) that can have beneficial pharmacologic actions. The present study was undertaken to investigate the effects of...
-
From:MPR Pharmacists' Edition (Vol. 4, Issue 3)COUNSELING NOTES Erectile dysfunction is treated by phosphodiesterase type 5 inhibitors or PDE5 inhibitors (sildenafil, tadalafil, vardenafil) or prostaglandin E1 (alprostadil). The PDE5 inhibitors are selective for...
-
From:MPR Pharmacists' Edition (Vol. 3, Issue 4)COUNSELING NOTES Erectile dysfunction is treated by phosphodiesterase type 5 inhibitors or PDE5 inhibitors (sildenafil, tadalafil, vardenafil) or prostaglandin E1 (alprostadil). The PDE5 inhibitors are selective for...
-
From:Practice Nurse (Vol. 25, Issue 1)Introduction Erectile dysfunction (ED) is defined as the inability to attain or maintain an erection sufficient for satisfactory sexual performance. (1) The number of men suffering from ED in the UK or worldwide is...
-
From:Canadian Urological Association Journal (Vol. 3, Issue 1) Peer-ReviewedAuthor(s): Anthony J. Bella, MD [1], Tom F. Lue, MD [2] Aparadigm shift in the management of erectile dysfunction (ED) secondary to prostate cancer surgery occurred with the introduction of cavernous nerve-sparing...
-
From:Review of Optometry (Vol. 145, Issue 3) Peer-ReviewedMore than 10 million men in the United States are affected by erectile dysfunction (ED), with more than six hundred thousand men between the ages of 40 and 69 developing ED annually. (1,2) The risk of ED is related to...
-
From:Review of Optometry (Vol. 146, Issue 5) Peer-ReviewedErectile dysfunction (ED) drugs, specifically Viagra (sildenafil citrate, Pfizer) and Cialis (tadalafil, Lilly), cause no vision problems or retinal abnormalities, at least over a six-month period, according to a study...
-
From:Contemporary Urology (Vol. 15, Issue 12) Peer-Reviewed
-
From:Journal of Family Practice (Vol. 52, Issue 1) Peer-ReviewedHong B, Ji YH, Hong JH, Nam Ky, Ahn TY A double-blind crossover study evaluating the efficacy of Korean red ginseng in patients with erectile dysfunction: a preliminary report. J Urol 2002; 168:2070-3. * PRACTICE...
-
From:Journal of Men's Health & Gender (Vol. 3, Issue 4) Peer-ReviewedWright PJ. Comparison of phosphodiesterase type 5 (PDE5) inhibitors. Int J Clin Pratt 2006;60:967-75. In this review paper, the author reviews in detail the three oral phosphodiesterase type 5 (PDE5) inhibitors,...
-
From:MPR Urologists’ Edition (Vol. 6, Issue 2)PRESCRIBING NOTES Erectile dysfunction is treated by phosphodiesterase type 5 inhibitors or PDE5 inhibitors (sildenafil, tadalafil, vardenafil) or prostaglandin [E.sub.1] (alprostadil). The PDE5 inhibitors are...
-
From:International Journal of Men's Health (Vol. 5, Issue 2) Peer-ReviewedTo the extent one equates male sexual satisfaction with unyielding erections and more enduring sexual performance, one cannot imagine a better historical era than one that offers the seemingly perfect medicinal answer...
-
From:Family Practice News (Vol. 33, Issue 15)SILVER SPRING, MD. -- New drugs for benign prostatic hypertrophy and erectile dysfunction are closer to becoming available in the United States, now that a Food and Drug Administration expert panel has agreed that the...
-
From:Progress in Health Sciences (Vol. 2, Issue 2) Peer-ReviewedObjective: To evaluate the efficacy, satisfaction, safety and tolerability of sildenafil taken as prescribed prior to anticipated sexual activity in male outpatients with erectile dysfunction (ED). Materials and...
-
From:Consultant (Vol. 48, Issue 5) Peer-ReviewedMy patient is a man in his early 70s who complains of lack of strength. His testosterone level is low, and his B12 level is low-normal. An endocrinologist recommended [B.sub.12] injections and testosterone. Because the...
-
From:Reactions Weekly (Issue 1315)Novacare LLC has announced the voluntary US recall of the following products marketed for erectile dysfunction (ED) or sexual enhancement: Stiff Nights, Aziffa, Size Matters, Erex, Mojo, Hard Drive, Eyeful, Red Magic,...